Orca Bio
California, US · 3 known investors
Orca Bio develops allogeneic T-cell immunotherapies for high-risk blood cancers including acute myeloid leukemia, acute lymphocytic leukemia, and myelodysplastic syndrome. The company is advancing precision cell therapy treatments for patients with blood cancers and autoimmune diseases.
Founders & leadership
J
JeroenCo-founder and President
N
NathanielCo-founder and Chief Executive Officer